{"name":"Precision BioSciences, Inc.","slug":"precision-biosciences-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"PBGENE-HBV","genericName":"PBGENE-HBV","slug":"pbgene-hbv","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"PBGENE-HBV","genericName":"PBGENE-HBV","slug":"pbgene-hbv","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxNcTk1MHktWlNPSGVuWFIxVEJyYzkxaXlUWEJ1LTJOdDJpLWtzMndCSDNCRHoxS3lXakFNS3ZMSjFZd3JHME54SWdHRkF4YTJ2YUU1dGhaS2lOVWJTZUIxUzVvLVhNblVZTDBzQ0cwUUlRUlpIeVdabGVMTFJvdXV2T1F5b2c4VjBTVjNMNXllQXhLTG1td2RpbWl3UXQ3YUJfVTFxTGVTQjdUenNCenEyVko4ckt3T2owdXRELV9acGhtQ2s?oc=5","date":"2026-03-02","type":"pipeline","source":"AD HOC NEWS","summary":"Precision BioSciences Stock: Can This Tiny Gene-Editing Play Survive the Cash Crunch? - AD HOC NEWS","headline":"Precision BioSciences Stock: Can This Tiny Gene-Editing Play Survive the Cash Crunch?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNV2NBNU52NW03VGsxQWNwRnp2eHFaTjBpa29qU0xwRjR0N3RBa212bWtVQjByYkhoM2lhbXBPOTkyREQwbjNpR24tbXpCRWNENTdobjdCX3dubF9XU1FZUkJvQnlqN3hlVENuTXljVE9nbXZaYnVNNy11WllJWG1XRTZCYW9UTzhCaDJBSlVtRDk2THRZM2VLMFdxV0tEdm1KTUN3d3ZLeHlMaGp3OVFPOXd2d2tqUQ?oc=5","date":"2025-12-29","type":"trial","source":"seekingalpha.com","summary":"Precision BioSciences: Potential Proof-Of-Concept Data For HBV Cure In 2026 (NASDAQ:DTIL) - seekingalpha.com","headline":"Precision BioSciences: Potential Proof-Of-Concept Data For HBV Cure In 2026 (NASDAQ:DTIL)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9iVUFUYkF6aGt3akxZT0hGaW1LLTVITDlQdFFCYUZkc2IwaDJKSHZpQ1d2VmtPWldraV9yWm9idUZab0xqcWZzdXllQ1BIaF9WUGVxcFJMNWhPakFld2QzRVg2dElTbkZjVjdzcEY3QmtFRG96SzhTT25aMkY?oc=5","date":"2025-12-17","type":"pipeline","source":"fiercebiotech.com","summary":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter - fiercebiotech.com","headline":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxQZWZ4Y2c3SVU3bzcxV1BRUzh0MWQ5X0sxQm1EbVg4S1YxdDY3eG1UNEU5TmtZR29kT2dVejZpTGZRVkVlR0ZUTmpmUXlpTXU2REliNFdQVWFTcTJfSWVJMWdielpSV2VIQVpUYnhfeGFFYWY3S3F6NmNoV0FabGVOT2NCejdEWThMZXpjajhXTXF0dkd3S3ZDVC1SUmZhZWpYTzBDcDN2TGJFUkVYMThaTzhEdkI3ZU1GTXFSWmZfcDB4Y0pYOHc5X3NvZENKWFVVYnhaUzA0X0ZncjQzeThlRWVPUFlOSWRlSlA4OEluTmFMNzE4a3Z0WjhGaE5hUXdiYnhOYkNB?oc=5","date":"2025-11-11","type":"pipeline","source":"BioSpace","summary":"Engineered T Cells Market Size Worth USD 616.91 Bn By 2034 Driven by Breakthroughs in Cancer Immunotherapy and Global Biotech Expansion - BioSpace","headline":"Engineered T Cells Market Size Worth USD 616.91 Bn By 2034 Driven by Breakthroughs in Cancer Immunotherapy and Global Bi","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-31","type":"pipeline","source":"simplywall.st","summary":"A great week that adds to Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns, institutional investors who own 46% must be happy - simplywall.st","headline":"A great week that adds to Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns, institutional investors who own ","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-07","type":"trial","source":"prnewswire.com","summary":"IDEAYA Biosciences and Hengrui Pharma Present Positive Phase 1 Data for IDE849 (SHR-4849), a Potential First-in-Class DLL3 TOP1 ADC, in Small Cell Lung Cancer at the IASLC 2025 World Conference on Lun","headline":"IDEAYA Biosciences and Hengrui Pharma Present Positive Phase 1 Data for IDE849 (SHR-4849), a Potential First-in-Class DL","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxOeWdyRUFZQVZCTWFULWFUVVhpWEppMEZoRkpCYjJFdURhbE1JWndaNkpybDFtWEVtX3plaS1pRGFhME9jd2kzNW0ybVpoLXRQa250UDBtSjNfX2htdi13U2JLdzdUN0trUkdyNlFSbXU5Z2ZYaS0yOXRPLUJlb0N0X0cyUnhucldMdl9ZTEdCdUNGV3BUQ2tqYVcxbGR6S2sxTzB5bjBUVUVwczNRYkpUTEtkUHdvYWx4X20zazFueG16RTV1emxwR1ZWRDREb19p?oc=5","date":"2025-08-12","type":"deal","source":"Bayer","summary":"Bayer and Kumquat Biosciences enter global exclusive license and collaboration in precision oncology - Bayer","headline":"Bayer and Kumquat Biosciences enter global exclusive license and collaboration in precision oncology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNWlB0aFdBUlVFeXdQajZvUUVBZktrMGpKTUNfR0JIZE9hel91NlpzY2dzTUpDbWlzT1lUNlZIcWdnZ1RncjQyV190bHFoRmlOUmRKdjBuZ0VLUVRtR3FvS0Zsa1dZZW96WmhHMURFSVRBN0c0M3pCOGNMbXU5bjNTZWJVb3hQMWJ0R0lCTjdCbFZpM1Zvdld6U2NFc0g0OUVOS3ZVQzRCb0V0U2Fib2FNVU9yX2RXR3BQZFY3THlteTJPVU5SLVhlckxBaVFwd0hGaVp2X0liemZlXzdGYU9OMHYyc09HVFRWeXgxaw?oc=5","date":"2025-08-12","type":"deal","source":"prnewswire.com","summary":"Bayer and Kumquat Biosciences enter global exclusive license and collaboration in precision oncology - prnewswire.com","headline":"Bayer and Kumquat Biosciences enter global exclusive license and collaboration in precision oncology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNUE5uUEw2UkZPN2FRWWZTbFJfREZkc2w0eHpYZDdLbHJJckxVSm1xdlRKV0hOSUpnYjNCWGdiNXNtWUZIa29GdlpwS3BYM1hnRFJscS1sRElxcERQUW5uWU9KdkNYUVQxX1lZd1hkbHZsc1dwNTFqRklKOU53MkNXRWRZVVRMWTNKWHg4c1JabGdsQ3Y2a3FZ?oc=5","date":"2025-06-18","type":"pipeline","source":"BioPharma Dive","summary":"A startup banks $66M to pursue ‘inclusive precision medicine’ - BioPharma Dive","headline":"A startup banks $66M to pursue ‘inclusive precision medicine’","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxNaUJ6dDFvRzRfNW16cEc3Q3F5bk04U2dKeDVCQ1k5T0phS2VSbGNjQmI2U2NoMGZjb3NIRk1iMjFuLUhSdUhrZTVlS2NfWnRnQ05yVnhfSmtfM2ZaU1E5U0pXNU9SR2xpaHkwa1RtSHhqZUk0R0RMRUNfckhVRk44V1E4NnRCOGxLYlprb080QlBERVJXNmpjUjNfa1NaZnVJYXJ6MUtoOFZ4MTNJbl9mdXZocnRrc3lyQk1BdzVRTVFaS1dBa18yYmFn?oc=5","date":"2025-05-08","type":"earnings","source":"businesswire.com","summary":"Precision BioSciences to Report First Quarter 2025 Results on May 15, 2025 - businesswire.com","headline":"Precision BioSciences to Report First Quarter 2025 Results on May 15, 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9uRjkzUlNTMTA3M2FEVlQ2MWZCX1MwaUp4eHJaYkhVN1BadDl1M3Zjb040ZGhBQTJvVG9BOUtuWU9rM0N1eFJ1dXplYlFuZkJBd25JYlQzZTEzWGhLeDR3bVBjWUQ4eWJQanYyVUNB?oc=5","date":"2024-07-03","type":"deal","source":"KED Global","summary":"Kwangdong Pharma acquires stake in Precision Bio - KED Global","headline":"Kwangdong Pharma acquires stake in Precision Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxPRTVsb252YU1udHA2dlJTc3pKTVZsRXMxcE9SQjlZYkRHaXB4TFB4ek1jVEY3WXE3LUtSNDEyemZUMl9qQmxNUHE2X2tOdUN3LVphbWRTOHVOajgwRWwtVmp1RXBfb0g0WHl1RWFCOVk3SWtaZTRiRUNpdkYyZVR3RUNRbVJUeWRDUHJmTlg0RDNtM2R5SENLdURDUmtyVUExVnlqdGY4X2ZUckp1NzAtLUlJMVc5RnA0MkVQYll5ZmtqQVJJRjg1WEcxcmp0R2JPbWZfdHBpNmxfZw?oc=5","date":"2022-05-23","type":"pipeline","source":"Precision BioSciences","summary":"Precision BioSciences Appoints Juli Blanche as Chief People Officer - Precision BioSciences","headline":"Precision BioSciences Appoints Juli Blanche as Chief People Officer","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}